Improving prostate cancer surgery while protecting quality of life

The Urology Foundation-funded research, led by Mr Matt Winkler and Nikhil Mayor at Imperial College London, explored a new imaging technology that could help surgeons make better decisions during prostate cancer surgery, potentially improving outcomes for thousands of men, whilst also saving the NHS money compared to the current standard of nerve sparing surgery.

Nikhil Mayor and Imperial Team
Nikhil Mayor 1
Nikhil Mayor and Imperial Team 3
Nikhil Mayor and Imperial Team 4

The challenge

During surgery to remove the prostate, surgeons often use a “nerve-sparing” approach to reduce the risk of side effects such as erectile dysfunction and urinary incontinence. However, operating close to these nerves can increase the chance of leaving behind small amounts of cancer at the edge of the removed tissue, known as positive surgical margins. Positive margins can increase the risk of the cancer returning or spreading.

 

Current methods for checking whether cancer has been completely removed during surgery are effective but are time-consuming, complex and require expert pathology staff to be available on-site during the operation (something most hospitals can’t offer). This means many patients cannot benefit from this important real-time assessment during their operation.

The research

The IP8-FLUORESCE study tested a newer, faster technology called fluorescence confocal microscopy (FCM). This scanner produces high-resolution microscopic images of tissue in the operating theatre within minutes, allowing surgeons to make sure they have removed enough tissue at the margins of the prostate without needing complex preparation or specialised staff. The aim of the study was to assess how accurate this technology is in detecting small areas of cancer left behind at the edge of the prostate compared to the gold standard test (histopathology).

 

The study, led by Chief Investigator, Mr Matt Winkler together with Nikhil Mayor, found that fluorescence confocal microscopy was highly accurate at identifying the most clinically important areas where cancer may have been left behind, while being quick and easy to use. Unlike current approaches, it does not require specialist pathology teams in the operating theatre, potentially making this type of assessment available to many more patients.

Our role

The Urology Foundation funded Nikhil Mayor and colleagues at Imperial College London to carry out the IP8-FLUORESCE study, providing one of the largest and most rigorous evaluations of fluorescence confocal microscopy in prostate cancer surgery to date. The research explored whether this technology could offer a simpler and more widely accessible alternative to existing intraoperative assessment techniques.

The Urology Foundation is extremely grateful to the John Black Charitable Foundation for supporting this work.

Impact of the study

This research identified fluorescence confocal microscopy as a promising new tool for prostate cancer surgery. Because it is quicker and easier to use than current approaches, it could enable more hospitals to assess surgical margins during an operation and support surgeons in deciding whether additional tissue should be removed.

 

In the future, this could help reduce the risk of cancer recurrence while allowing more men to benefit from nerve-sparing surgery, preserving erectile function and quality of life wherever possible. The findings have already attracted international interest and have been presented at major urology conferences, helping to advance the field of precision prostate cancer surgery.

 

Nikhil Mayor, Clinical Research Fellow at Imperial College London, said: “Surgery for prostate cancer has traditionally been a trade-off between controlling the cancer and preserving erectile function and continence.

Intraoperative margin assessment with FCM could improve the balance by giving surgeons real-time feedback during the operation.

The IP8-FLUORESCE study has provided some of the first robust evidence for FCM in prostate surgery but more evidence is still needed before we can start using it in practice.”

 

Next steps

The findings provide a strong foundation for further research to determine whether using fluorescence confocal microscopy during surgery improves long-term outcomes for patients, including cancer control, continence and erectile function. Researchers are also exploring ways to enhance the technology, including the development of artificial intelligence tools to help interpret images and larger multi-centre studies to validate the results. Ultimately, this work could help bring real-time surgical decision-making to more hospitals and more patients.

 

Publication: IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy, European Urology (2026) Available: https://www.sciencedirect.com/science/article/pii/S0302283825047323

£1 box

Get involved

Whether it's funding research, supporting urology healthcare professionals, raising awareness of urology health or campaigning, we couldn't do it without your support

Ways to make a difference

All the work we do to fight urology disease is funded by supporters across the country. We can only continue our vital work with support from people like you.

When you donate to The Urology Foundation you join the front line of the fight against urology disease. Your money helps us to:

  • Invest in ground breaking research into urology diseases so that we can find better cures and treatments
  • Provide training and education to equip all urology professionals with the tools they need to support and treat patients in hospitals across the UK and Ireland
  • Drive change based on research outcomes